Advertisement

Diabetic Foot

  • Frank Lee Bowling
  • Andrew J. M. Boulton
Reference work entry
Part of the Endocrinology book series (ENDOCR)

Abstract

Diabetic foot problems are eminently preventable and yet represent one of the commonest causes of hospital inpatient admission in Western countries. Realizing the global importance of diabetic foot disease, the International Diabetes Federation focused on the diabetic foot throughout the year 2005, during which there was a worldwide campaign to “put feet first” and highlight the all too common problem of amputation among patients with diabetes throughout the world. To coincide with World Diabetes Day in 2005, The Lancet launched an issue almost exclusively dedicated to the diabetic foot: this was the first time that any major non-specialist journal had focused on this worldwide problem; however, major challenges remain in getting across important messages relating to the diabetic foot. The late sequelae of diabetic peripheral neuropathy include foot ulceration, Charcot neuroarthropathy, and amputation: likewise, peripheral vascular disease is a major etiological factor in diabetic foot lesions. Today, in many countries, it is neuro-ischemic ulcers which are most commonly seen and which present a major challenge in management. The importance of routine diabetic foot care in very high-risk patients is emphasized by a recent observational study from Arizona where the state decided, as a cost-saving measure, to remove routine podiatry from high-risk diabetic patients. This led to an annual saving of $351,000, but the cost of this action measured by increased hospitalization, length of stay, and amputations was $16.7 million per annum.

Keywords

Diabetes Peripheral vascular disease Charcot neuroarthropathy Diabetic peripheral neuropathy 

References

  1. Abbott CA, Carrington AL, Ashe H, Bath S, Every LC, Griffiths J, et al. The North-West Diabetes Foot Care Study: incidence of, and risk factors for new diabetic foot ulceration in a community-based patient cohort. Diabet Med. 2002;19:377–84.CrossRefGoogle Scholar
  2. American Diabetes Association. Microvascular complications and foot care. Diabetes Care. 2015;38:S58–66.CrossRefGoogle Scholar
  3. Armstrong DG, Lavery LA. Diabetic Foot Study Consortium. Negative pressure wound therapy after partial diabetic foot amputation: a multicentre, randomised controlled trial. Lancet. 2005;366:1704–10.CrossRefGoogle Scholar
  4. Armstrong DG, Lavery LA, Kimbriel HR, Nixon BP, Boulton AJM. Activity patterns of patients with diabetic foot ulceration: patients with active ulceration may not adhere to a standard pressure off-loading regimen. Diabetes Care. 2003;26:2595–7.CrossRefGoogle Scholar
  5. Armstrong DG, Lavery LA, Wu S, Boulton AJ. Evaluation of removable and irremovable cast walkers in the healing of diabetic foot wounds: a randomised controlled trial. Diabetes Care. 2005;28:551–4.CrossRefGoogle Scholar
  6. Armstrong DG, Boulton AJM, Bus SA. Diabetic Foot Ulcers and their recurrence. N Engl J Med 2017;376:2367–2375.CrossRefGoogle Scholar
  7. Bakker K, Apelqvist J, Lipsky BA, Van Netten JJ, et al. The 2015 IWGDF guidance documents on prevention and management of foot problems in diabetes: development of an evidence based global consensus. Diabetes Metab Res Rev. 2016;32:2–6.CrossRefGoogle Scholar
  8. Boulton AJM. Management of diabetic peripheral neuropathy. Clin Diabetes. 2005;23:9–15.CrossRefGoogle Scholar
  9. Boulton AJM, Malik RA, Arezzo JL, Sosenko JM. Diabetic somatic neuropathies: technical review. Diabetes Care. 2004;27:1458–86.CrossRefGoogle Scholar
  10. Boulton AJM, Vileikyte L, Ragnaarson-Tennvall G, Apelqvist J. The global burden of diabetic foot disease. Lancet. 2005;366:1719–24.CrossRefGoogle Scholar
  11. Boulton AJM, Armstrong DG, Albert SF, Frykberg RG, Hellman R, Kirkman MS, et al. Comprehensive foot examination and risk assessment. Diabetes Care. 2008;31:1679–85.CrossRefGoogle Scholar
  12. Bowling FL, Abbott CA, Harris WE, et al. A pocket-sized disposable device for testing the integrity of sensation in the outpatient setting. Diabet Med. 2012;29:1550–2.CrossRefGoogle Scholar
  13. Cavanagh P, Attinger C, Abbas Z, Bal A, Rojas N, Xu ZR. The cost of treating diabetic foot ulcers in 5 different countries. Diabetes Metab Res Rev. 2012;28:107–11.CrossRefGoogle Scholar
  14. Citron DM, Goldstein EJ, Merriam CV, Lipsky BA, Abramson MA. Bacteriology of moderate-to-severe diabetic foot infections and in vitro activity of antimicrobial agents. J Clin Microbiol. 2007;45:2819–28.CrossRefGoogle Scholar
  15. Cruciani M, Lipsky BA, Mengoli C, de Lalla F. Granulocyte-colony stimulating factors as adjunctive therapy for diabetic foot infections. Cochrane Database Syst Rev. 2013;10:CD006810.Google Scholar
  16. Department of Health. Six years on delivering the national service framework in diabetes. (2010). http://nationalarchives.gov.uk
  17. Diabetes UK. Cost of diabetes report. 2014. Available from http://www.diabetes.org.uk/Documents/CostofDiabetes
  18. Dunville JC, Hinchliffe RA, Cullum N, et al. Negative pressure wound therapy for treating foot wounds in people with diabetes mellitus. Cochrane Database Syst Rev. 2013;10:CD010318.Google Scholar
  19. Game FL, Apelqvist J, Attinger C, et al. Effectiveness of interventions to enhance healing of chronic ulcers of the foot in diabetes: a systematic review. Diabetes Metab Res Rev. 2016;32:154–68.CrossRefGoogle Scholar
  20. Gonzalez JS, Vileikyte L, Ulbrecht JS, Rubin RR, Garrow AP, Delgado C, Cavanagh PR, Boulton AJM, Peyrot M. Depression predicts first but not recurrent diabetic foot ulcers. Diabetologia. 2010;53:2241–8.CrossRefGoogle Scholar
  21. Health and Social Care Information Centre, National Diabetes In-patient Audit 2012. (2013). https://catalogue.ic.nhs.uk/publications/clinical/diabetes/nati-diab-inp-audi-12/nati-diab-inp-audi-12-nat-rep.pdf
  22. Holman N, Young RJ, Jeffocate WJ. Variation in the recorded incidence of amputation of the lower limb in England. Diabetologia. 2012;55:1919–25.CrossRefGoogle Scholar
  23. International Diabetes Federation guidelines for type 2 diabetes. www.idf.org/sites/default/files/IDF-Guideline-for-Type-2-Diabetes.pdf
  24. Inzucchi SE, Bergenstal R, Buse J, Diamant M, Ferrannini E, Nauck M, Mathews D. Management of hyperglycaemia in type 2 diabetes, a patient centred approach: update to a position statement of the American Diabetes Association and the European Association for the study of diabetes. Diabetes Care. 2015;38:140–9.CrossRefGoogle Scholar
  25. Jeffcoate WJ, Bus SA, Game FL, et al. Reporting standards of studies and papers on the prevention and management of foot ulcers in diabetes: required details and markers of good quality. Lancet Diabetes Endocrinol. 2016;4:781–8.CrossRefGoogle Scholar
  26. Jeffocate WJ, Young RJ. National diabetic foot audit of England and Wales yields its first dividends. Diabet Med. 2016;33:1464–5.CrossRefGoogle Scholar
  27. Katz IA, Harlan A, Miranda-Palma B, Prieto-Sanchez L, et al. A randomized trial of two irremovable off-loading devices in the management of plantar neuropathic diabetic foot ulcers. Diabetes Care. 2005;28:555–9.CrossRefGoogle Scholar
  28. Kerr M, Rayman G, Jeffcoate WJ. Cost of diabetic foot disease to the National Health Service in England. Diabet Med. 2014;(12):1498–504.CrossRefGoogle Scholar
  29. Krishnan S, Nash F, Baker N, Fowler D, Rayman G. Reduction in diabetic amputations over 11 years in a defined UK population: benefits of multidisciplinary team work and continuous prospective audit. Diabetes Care. 2008;31:99–101.CrossRefGoogle Scholar
  30. Lavery LA, Higgins KR, Lanctot DR, et al. Preventing diabetic foot ulcer recurrence in high risk patients. Use of temperature monitoring as a self-assessment tool. Diabetes Care. 2007;30:114–20.CrossRefGoogle Scholar
  31. Lavery LA, Lavery DC, Hunt NA, LaFontaine J, Ndip A, Boulton AJM. Amputations and foot-related hospitalizations disproportionately affect dialysis patients. Int Wound J. 2015;12(5):523–6.CrossRefGoogle Scholar
  32. Leese GP, Stang D, McKnight JA, The Scottish Diabetes Foot Action Group. A national strategic approach to diabetic foot disease in Scotland: changing a culture. Br J Diabetes Vasc Dis. 2011;11(2):69–73.CrossRefGoogle Scholar
  33. Lipsky BA, Berendt AR, Cornia PB, et al. Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis. 2012;54:e132–73.CrossRefGoogle Scholar
  34. Löndahl M, Katzman P, Nilsson A, et al. Hyperbaric oxygen facilitates healing of chronic foot ulcers in patients with diabetes. Diabetes Care. 2010;33:998–1003.CrossRefGoogle Scholar
  35. Nabuurs-Franssen MH, Sleegers R, Huijberts MS, Wijnen W, Sanders AP, Walenkamp G, et al. Total contact casting of the diabetic foot in daily practice a prospective follow up study. Diabetes Care. 2005;28:243–7.CrossRefGoogle Scholar
  36. National Institute for Clinical Excellence 2004. Clinical guidelines for type 2 diabetes: Prevention and management of foot problems (CG10). http://w.w.w.nice.org.uk/guidance/cg10/resources/cg10-type-2-diabetes-footcare-information-for-the-public2
  37. Ndip A, Rutter MK, Vileikyte L, et al. Dialysis is an independent risk factor for foot ulceration in patients with diabetes and chronic kidney disease. Diabetes Care. 2010;33:1811–6.CrossRefGoogle Scholar
  38. Oyibo S, Jude EB, Tarawneh I, Nguyen HC, Harkless LB, Boulton AJ. A comparison of two diabetic foot ulcer classification systems. Diabetes Care. 2001;24:84–8.CrossRefGoogle Scholar
  39. Pecoraro RE, Reiber GE, Burgess EM. Pathways to diabetic limb amputation: basis for prevention. Diabetes Care. 1990;13:513–21.CrossRefGoogle Scholar
  40. Peters EJ, Lipsky BA, Aragon-Sanchez J, et al. Interventions in the management of infection in the foot in diabetes: a systematic review. Diabetes Metab Res Rev. 2016;32:145–53.CrossRefGoogle Scholar
  41. Piaggesi A, Macchiarini S, Rizzo L, Palumbo F, Tedeschi A, Nobili LA, Del Prato S. An off the shelf instant contact casting device for the management of diabetic foot ulcers: a randomised prospective trial versus traditional fiberglass cast. Diabetes Care. 2007;30:586–90.CrossRefGoogle Scholar
  42. Pop-Busui R, Boulton AJ, Feldman EL, Brill V, Freeman R, et al. Diabetic neuropathy: a position statement by the American Diabetes Association. Diabetes Care. 2017;40:136–54.CrossRefGoogle Scholar
  43. Prompers L, Huijberts M, Scaper N, et al. Resource utilisation and costs associated with the treatment of diabetic foot ulcers. Prospective data from the Eurodiale study. Diabetologia. 2008;51:1826–34.CrossRefGoogle Scholar
  44. Rayman G, Vas PR, Baker N, et al. The Ipswich Touch Test: a simple and novel method to identify in patients with diabetes at risk of foot ulceration. Diabetes Care. 2011;34:1517–8.CrossRefGoogle Scholar
  45. Reiber GE, Vilikeyte L, Boyko E, del Aquila M, Smith DG, Lavery LA, Boulton AJM. Causal pathways for incident lower extremity ulcers in patients with diabetes from 2 settings. Diabetes Care. 1999;22:157–62.CrossRefGoogle Scholar
  46. Rogers LC, Frykberg RG, Boulton AJM. The Charcot foot in diabetes. Diabetes Care. 2011;34:2123–9.CrossRefGoogle Scholar
  47. Schaper NC, Andros G, Apelqvist J, et al. Diagnosis and management of peripheral arterial disease in diabetic patients with a foot ulcer. Diabetes Metab Res Rev. 2012;28:218–24.CrossRefGoogle Scholar
  48. Shen W, Wukich D. Orthopaedic surgery and the diabetic Charcot foot. Med Clin N Amer. 2013;97:873–82.CrossRefGoogle Scholar
  49. Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA. 2005;293:217–28.CrossRefGoogle Scholar
  50. Skrepnek GH, Mills JL, DG A. Foot-in-wallet disease: tripped up by “cost saving” reductions? Diabetes Care. 2014;37:e196–7.CrossRefGoogle Scholar
  51. Stoekenbroek RM, Santema TB, Koelemay MJ, et al. Is additional hyperbaric oxygen therapy cost-effective for treating ischemic diabetic ulcers? Protocol for the Dutch DAMOCLES multicentre randomized clinical trial. J Diabetes. 2015;7:125–32.CrossRefGoogle Scholar
  52. Tentolouris N, Achtsidis V, Marinou K, Katsilambros N. Evaluation of the self-administered indicator plaster neuropad for the diagnosis of neuropathy in diabetes. Diabetes Care. 2008;31:236–7.CrossRefGoogle Scholar
  53. Tentolouris N, Marinou K, Kokotis P, Karanti A, Diakoumopoulou E, Katsilambros N. Sudomotor dysfunction is associated with foot ulceration in diabetes. Diabet Med. 2009;26:302–5.CrossRefGoogle Scholar
  54. The diabetes control and complications research group. Effect of intensive treatment of diabetes on the development and progression of long term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–86.CrossRefGoogle Scholar
  55. Uckay I, Gariani K, Pataky Z, Lipsky BA. Diabetic foot infections: state-of-the-art. Diabetes Obes Metab. 2014;16:305–16.CrossRefGoogle Scholar
  56. Valk GD, de Sonnaville JJ, van Houtum WH, et al. The assessment of diabetic polyneuropathy in daily clinical practice: reproducibility and validity of Semmes Weinstein monofilaments examination and clinical neurological examination. Muscle Nerve. 1997;20:116–8.CrossRefGoogle Scholar
  57. van Schie CH, Abbott CA, Vileikyte L, Shaw JE, Hollis S, Boulton AJM. A comparative study of the Podotrack, a simple semi-quantitative plantar pressure measuring device, and the optical paedobarograph in the assessment of pressures under the diabetic foot. Diabet Med. 1999;16:144–59.Google Scholar
  58. Vileikyte L. Psychosocial and behavioural aspects of diabetic foot lesions. Curr Diab Rep. 2008;8:119–25.CrossRefGoogle Scholar
  59. Vileikyte L, Rubin RR, Leventhal H. Psychological aspects of diabetic neuropathic foot complications: an overview. Diabetes Metab Res Rev. 2004;20:13–8.CrossRefGoogle Scholar
  60. Weck M, Slesaczeck T, Paetzold H, et al. Structured healthcare for subjects with diabetic foot ulcers results in major reduction of amputation rates. Cardiovasc Diabetol. 2013;12:45.CrossRefGoogle Scholar
  61. Young MJ, Breddy JL, Veves A, Boulton AJM. The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds. A prospective study. Diabetes Care. 1994;17:557–600.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Frank Lee Bowling
    • 1
    • 2
    • 3
  • Andrew J. M. Boulton
    • 4
    • 5
    • 6
    • 7
  1. 1.Division of SurgeryManchester Royal InfirmaryManchesterUK
  2. 2.Faculty of Medicine, Biology and HealthUniversity of ManchesterManchesterUK
  3. 3.Vascular Surgery and DiabetesCentral Manchester University Hospital – NHS Foundation TrustManchesterUK
  4. 4.Division of Endocrinology, Diabetes and Gastroenterology, Faculty of Medicine, Biology and HealthUniversity of ManchesterManchesterUK
  5. 5.Department of MedicineUniversity of ManchesterManchesterUK
  6. 6.Manchester Royal InfirmaryManchesterUK
  7. 7.Diabetes Research InstituteUniversity of MiamiMiamiUSA

Personalised recommendations